Back to Peptide Pedia
Immune & Vitality
Limited Research

VIP

VIP

Neuropeptide studied in immune and vascular research.

Also known as: Vasoactive Intestinal Peptide

Research dose range50 mcg per spray (research models)
Route studiedIntranasal / subcutaneous
Study durationSeveral times daily (intranasal)
Storage2–8 °C reconstituted

Overview

VIP (Vasoactive Intestinal Peptide) is a neuropeptide studied in immune-modulation, vascular, and inflammatory research.

Key research findings

Vasoactive Intestinal Peptide is a 28-amino-acid neuropeptide with broad anti-inflammatory, immune-modulating, and vasodilatory roles. It is studied notably as an intranasal protocol in chronic inflammatory response syndrome (CIRS) research and for pulmonary and gut applications.

Mechanism of action

Binds VPAC receptors to influence vasodilation, anti-inflammatory signaling, and circadian regulation.

Molecular information

Weight3,326 Da
Length28 amino acids
TypeVasoactive intestinal neuropeptide

A member of the secretin/glucagon peptide superfamily; signals via VPAC receptors.

Pharmacokinetics

Peak: ~0.25 hoursHalf-life: ~1–2 minutes (very short)Cleared: ~2 hours
Peak · 0hHalf-life · 1h

Illustrative relative-concentration model derived from published pharmacokinetic research. Curve is normalized and provided for educational comparison only — not a dosing schedule.

Research applications

  • Immune-modulation research
  • Vascular studies
  • Inflammation and circadian investigations

Research protocols

Protocols summarized from published research models. Provided for scientific reference only — not dosing guidance for human use.

Intranasal referenceAmount: 50 mcgFrequency: Up to 4× dailyRoute: Intranasal
Conservative referenceAmount: 25–50 mcgFrequency: TitratedRoute: Intranasal

Observed effects timeline

Aggregated observations reported across research literature. Timing and magnitude vary by model and are not a guarantee of outcome.

  1. Acute

    Vasodilatory and anti-inflammatory signaling reported shortly after dosing.

  2. Week 4+

    Changes in inflammatory and pulmonary markers reported in CIRS research protocols.

Research compatibility

Describes how compounds are studied alongside one another in the literature. Not a recommendation to co-administer.

KPV

Complementary anti-inflammatory pathways.

Compatible

Thymosin Alpha-1

Distinct immune-modulating mechanism.

Compatible

DSIP

Distinct neuropeptide pathways.

Compatible

How to reconstitute

Important

Reconstitute with bacteriostatic water, swirl gently, and refrigerate. VIP is very fragile — handle gently and keep cold.

  1. 1Allow the vial to reach room temperature (15–20 minutes).
  2. 2Swab the stopper with alcohol and let it air dry.
  3. 3Add bacteriostatic water slowly down the vial wall.
  4. 4Swirl gently until dissolved — do not shake.
  5. 5Refrigerate at 2–8 °C and protect from light.
Open reconstitution calculator

Quality indicators

Uniform white powder

Lyophilized cake should be white to off-white without discoloration.

Clear solution

Reconstitutes to a clear, colorless, particle-free solution.

Cold-chain integrity

Reconstituted solution requires 2–8 °C storage.

Slight clumping

Small clumps that dissolve completely with gentle swirling are acceptable — shipping can cause minor compaction.

Collapsed or melted appearance

Powder that looks collapsed, melted, or stuck to the vial walls may have been exposed to heat in transit.

Cloudy after reconstitution

Persistent cloudiness, particles, or precipitate after gentle mixing can indicate a degraded or contaminated peptide.

Reported observations & safety

Safety signals reported in the research literature. Compiled for scientific awareness — not medical advice.

  • Flushing, lowered blood pressure, and lightheadedness are reported due to vasodilatory activity.
  • CIRS research protocols emphasize addressing underlying exposures before VIP use.

References & further reading

Vasoactive intestinal peptide: immune and vascular roles (review)

Preclinical/humanVPAC receptorsanti-inflammatory

Review of VIP's broad anti-inflammatory, immune-modulating, and vasodilatory actions.

View study

Topics

neuropeptidevascularimmune

This entry is provided for educational and informational purposes only. It is not medical advice, a dosing protocol, or a claim of therapeutic benefit. Research compounds are supplied strictly for laboratory and research use — not for human or veterinary consumption.

Research level
Limited Research

Sparse published data; largely preliminary or anecdotal.

Quick reference
Dose range50 mcg per spray (research models)
RouteIntranasal / subcutaneous
DurationSeveral times daily (intranasal)
Storage2–8 °C reconstituted
Half-life~1–2 minutes (very short)
Catalogue status

This compound is part of our educational reference and is not currently stocked. Browse the catalogue for available research-grade peptides.

Browse catalogue